MRNA Moderna Inc
Company Analysis
Latest News
🔴 Moderna is trading 10.3% down today amid biotech-sector selling
Moderna is trading at $212.16, down 10.29%, amid an active biotech-sector selloff. - XBI was down 2.06% during the regular session. - Citi’s recent Sell...
🔴 Moderna is trading 5.8% down today, extending losses after Citi’s recent downgrade citing valuation concerns
- Moderna is trading 5.8% down at $222.80, with today's decline influenced by Citi's September 30, 2026, downgrade to Sell and its $80 price target, reflecting...
🟢 Moderna is trading 5% up
Moderna is trading 5.07% up at $237.77 on October 15, with no verified report tying the move to company-specific news and biotech strength offering a possible...
🟢 Moderna is trading 4.2% up without a clear catalyst
Moderna is trading up 4.2% at $225.34 on October 14; coverage describes an intraday rebound but identifies no clear catalyst. - The recent rally has been...
🔴 Moderna is trading 4.04% down today in a post-rally pullback
Moderna is trading 4.04% down at $215.91 on October 12, in a pullback following Friday’s sharp rally. - No fresh company-specific announcement explaining the...
🟢 Moderna is trading 10% up today after Nasdaq-100 inclusion, with possible index-fund buying
Moderna is trading at $217.37, up 10.34%, with its Nasdaq-100 inclusion the clearest company-specific catalyst. - The inclusion took effect before the market...
Moderna's 8% Pop on Nasdaq-100 Inclusion: Can Passive Fund Buying Sustain a Stock That Has Struggled for Years?
Shares of Moderna surged 8.3% to $213.38 on October 9 as the biotech's addition to the Nasdaq-100 index took effect before the opening bell, forcing billions...
🟢 Moderna is trading 8% up today amid potential Nasdaq-100 fund buying
Moderna is trading 8.31% higher at $213.38, with Nasdaq-100 inclusion-related buying the clearest catalyst. - Nasdaq confirmed the addition, effective before...
Moderna Launches First mRNA Flu Vaccine, mFlusiva, for 2026–27 Season
Moderna’s first mRNA-based seasonal flu vaccine, mFlusiva, is now available in the U.S. for the 2026–2027 flu season. [4, 11] The FDA approved it in August...
🟢 Moderna is trading 4.08% up amid expanded Tempus cancer-therapy collaboration
Moderna is trading 4.08% up at $195.10 on October 7, 2026, amid Tempus’s expanded collaboration with Moderna and Merck; available reporting does not establish...
🔴 Moderna is trading 4.2% down with no verified company-specific catalyst
Moderna is trading 4.2% lower at $194.67, with no verified company-specific announcement identified to explain the October 6 decline. - The October 5 gain...
🟢 Moderna is trading 4.5% up today with no verified catalyst reported
Moderna is trading at $198.57, up 4.51%, with no clearly verified Moderna-specific announcement explaining the October 5 move. - Nasdaq-100 inclusion,...
Moderna Joins Nasdaq-100, Prompting Index Funds to Buy Shares
Nasdaq said Moderna (MRNA) will join the Nasdaq-100 Index before the market opens on October 9, 2026. Moderna will replace Warner Bros. Discovery (WBD) in the...
Moderna Loses Government-License Defense in Northwestern Patent Case
A federal judge in Delaware rejected Moderna’s argument that a U.S. government license stemming from federally funded research shielded the company from patent...
🟢 Moderna is trading 4.02% up with no clear catalyst identified
Moderna is trading at $200.31, up 4.02% on October 1, 2026; no clear company-specific announcement explaining the gain appeared in available search results. -...
Moderna Appoints Former Executive Juan Andres to New Chief Operating Officer Role
Moderna announced it has created a new Chief Operating Officer (COO) role and appointed former executive Juan Andres to the position, effective October 5,...
🔴 Moderna is trading 4.03% down in pre-market with no confirmed catalyst
Moderna is trading 4.03% down at $195.26 in pre-market on September 30; no reliable report directly ties the move to a new announcement. - A Delaware judge...
🟢 Moderna is trading 5% up; no clear catalyst identified
Moderna is trading 5.35% higher at $207.84 on September 29, 2026, with no reliable report identifying a specific catalyst. - Major indices are nearly flat,...
🔴 Moderna is trading 4.52% down today amid oil-driven inflation concerns
Moderna is trading 4.52% lower at $189.90 amid broader risk-off sentiment linked to higher oil and renewed inflation concerns. - President Trump’s rejection of...
🔴 Moderna is trading 4.23% down in pre-market amid weaker global risk sentiment
Moderna is trading 4.23% down at $190.47 in pre-market on September 28; weaker global risk sentiment may be contributing, but no clear new company-specific...